Betta Pharmaceuticals Market Cap

Betta Pharmaceuticals has a market cap or net worth of 19.23 billion as of February 2, 2026. Its market cap has decreased by -10.94% in one year.

Market Cap

19.23B

Enterprise Value

21.27B

Revenue

3.26B

Ranking

n/a

PE Ratio

63.43

Stock Price

45.96

Market Cap Chart

Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 19.23B, an increase of 89.52%. That is a compound annual growth rate of 7.17%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	19.80B	0.81%
Dec 31, 2025	19.64B	-12.96%
Dec 31, 2024	22.57B	4.62%
Dec 29, 2023	21.57B	5.11%
Dec 30, 2022	20.53B	-38.09%
Dec 31, 2021	33.15B	-25.26%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 7, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zhejiang Huahai Pharmaceutical	23.43B
Tasly Pharmaceutical Group	22.56B
Joincare Pharmaceutical Group Industry	21.35B
Apeloa Pharmaceutical Co.,Ltd	21.08B
Walvax Biotechnology	20.20B
China Resources Double-Crane Pharmaceutical	19.37B
Shandong Buchang Pharmaceuticals	17.94B
Tonghua Dongbao Pharmaceutical	17.59B

Market Cap Rankings